Top Story

Genetic variant reduces coronary events, increases diabetes risk in familial hypercholesterolemia

June 30, 2015

CHICAGO — A PCSK9 loss-of-function genetic variant was associated with a cardioprotective effect, but increased prevalence of diabetes and prediabetes in patients with familial hypercholesterolemia, according to results presented at the National Lipid Association Scientific Sessions.

Researchers performed genotyping in 724 patients with familial hypercholesterolemia and established the presence of the PCSK9 InsLEU genetic variant to determine its potential link to diabetes, glucose homeostasis and coronary events.

Medicare fraud takedown: A closer look Health Care Legislative and Regulatory Update

Medicare fraud takedown: A closer look

June 30, 2015
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
In the Journals

Current monitoring of ICDs, pacemakers may underestimate device malfunction

June 30, 2015
The current monitoring of patients with cardiac implantable electronic devices may underestimate device malfunctions, leading researchers to propose new systematic…
In the Journals

Renal sympathetic denervation may reduce arrhythmic burden in patients with ICDs

June 30, 2015
Renal sympathetic denervation reduced arrhythmic episodes in a small cohort of patients with implantable cardioverter defibrillators, according to recent…
SupplementSupplement

Cardiology Today offers resource featuring expert perspectives from the ACC Annual Scientific Sessions

Cardiology Today, June 2015
Cardiology Today has released a resource for cardiologists that pools coverage from the American College of Cardiology’s 64th Annual Scientific Sessions…
More News Headlines »
CME
Antiplatelet Agents in ACS Distinguishing Characteristics Safety and Efficacy

Antiplatelet Agents in ACS: Distinguishing Characteristics, Safety, and Efficacy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Meeting News Coverage Video
VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

June 28, 2015
NEW ORLEANS – Joseph Ho, PharmD, clinical pharmacist with Ochsner Baptist Medical Center in New Orleans…
More »
CME
Cardiology Case Consults

The Patient with Acute Coronary Syndrome

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with acute coronary syndrome.
More »
morganatic-roan
morganatic-roan